ImageneBio (IMA) Assets Average (2021 - 2025)

ImageneBio has disclosed Assets Average across 5 years of filings, most recently posting $156.9 million for Q4 2025.

• In Q4 2025, Assets Average rose 90.32% year-over-year to $156.9 million; the TTM figure through Dec 2025 stood at $156.9 million (up 90.32% YoY), while the FY2025 annual figure was $84.4 million, down 18.8% from the prior year.
• Assets Average came in at $156.9 million for Q4 2025 at ImageneBio, up from $143.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $286.2 million in Q2 2021 to a low of $73.4 million in Q1 2025.
• Average Assets Average over 5 years is $184.5 million, with a median of $181.9 million recorded in 2022.
• The largest YoY upside for Assets Average was 90.32% in 2025 against a maximum downside of 59.78% in 2025.
• Over 5 years, Assets Average stood at $254.8 million in 2021, then declined by 28.82% to $181.4 million in 2022, then climbed by 12.32% to $203.7 million in 2023, then sank by 59.52% to $82.5 million in 2024, then surged by 90.32% to $156.9 million in 2025.
• Per Business Quant data, the three most recent Assets Average figures were $156.9 million in Q4 2025, $143.5 million in Q3 2025, and $128.5 million in Q2 2025.